{
    "name": "treprostinil inhaled",
    "comment": "Rx",
    "other_names": [
        "Tyvaso",
        "Tyvaso DPI"
    ],
    "classes": [
        "PAH",
        "Prostacyclin Analogs"
    ],
    "source": "https://reference.medscape.com/drug/tyvaso-tyvaso-dpi-treprostinil-inhaled-4000061",
    "pregnancy": {
        "common": [
            "Limited case reports of treprostinil insufficient to inform a drug-associated risk of adverse developmental outcomes; however, there are risks to mother and fetus associated with pulmonary arterial hypertension associated with an increased risk of maternal and fetal mortality; in animal studies, no adverse reproductive and developmental effects observed"
        ],
        "specific": [
            {
                "type": "Animal data",
                "description": [
                    "Animal reproductive studies have shown an adverse effect on fetus; in rats, administration to pregnant rats during period of organogenesis at doses greater than or equal to 10 mg/kg/day (approximately 15 times the human exposure at the dose of 3.5 mg BID on an AUC basis) resulted in decreased pregnancy rate, increased post-implantation loss, and decreased fetal viability and growth",
                    "In rabbits, teratogenicity and decreased fetal viability and growth were observed at doses greater than or equal to 1.5 mg/kg/day (approximately 7 times the human exposure at dose of 3.5 mg BID on an AUC basis)"
                ]
            },
            {
                "type": "Clinical considerations",
                "description": [
                    "Pulmonary arterial hypertension is associated with an increased risk of maternal and fetal mortality"
                ]
            }
        ]
    },
    "lactation": {
        "common": [
            "Data are not available regarding presence in human milk, effects on breastfed infants, or effects on milk production"
        ]
    },
    "warnings": {
        "black_box_warning": {
            "common": [],
            "specific": []
        },
        "contraindicators": {
            "common": [
                "None"
            ],
            "specific": []
        },
        "cautions": {
            "common": [
                "Efficacy of treprostinil inhaled has not been established in patients with significant underlying lung disease (eg, asthma or chronic obstructive pulmonary disease); monitor patients with acute pulmonary infections to detect any worsening of lung disease and loss of drug effect",
                "May produce symptomatic hypotension in patients with low systemic arterial pressure",
                "Titrate slowly in patients with hepatic or renal insufficiency",
                "Inhibits platelet aggregation and increases the risk of bleeding"
            ],
            "specific": [
                {
                    "type": "Bronchospasm",
                    "description": [
                        "As with other inhaled prostaglandins, therapy may cause acute bronchospasm",
                        "Patients with asthma or chronic obstructive pulmonary disease (COPD), or other bronchial hyperreactivity, are at increased risk for bronchospasm",
                        "Ensure that such patients are treated optimally for reactive airway disease prior to and during treatment "
                    ]
                },
                {
                    "type": "Drug interaction overview",
                    "description": [
                        "Oral treprostinil is a CYP2C8 substrate",
                        "It is unclear if systemic exposure of treprostinil by the inhalation route are altered by inhibitors or inducers of CYP2C8"
                    ]
                }
            ]
        }
    },
    "interactions": [],
    "adverse effects": [
        {
            "name": "Cough",
            "percent": "54"
        },
        {
            "name": "Headache",
            "percent": "41"
        },
        {
            "name": "Throat irritation",
            "percent": "25"
        },
        {
            "name": "pharyngolaryngeal pain",
            "percent": "19"
        },
        {
            "name": "Nausea",
            "percent": "15"
        },
        {
            "name": "Flushing",
            "percent": "6"
        },
        {
            "name": "Syncope",
            "percent": null
        },
        {
            "name": "Angioedema",
            "percent": null
        }
    ]
}